openPR Logo
Press release

Neuromodulation Devices Market Top Key Players, Industry Analysis And Forecast By 2027 | Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC.

10-20-2021 12:34 PM CET | Health & Medicine

Press release from: UnivDatos Market Insights (UMI)

Neuromodulation Devices Market Top Key Players, Industry

Neuromodulation Devices Market is expected to exceed the market valuation of more than US$ 11.7 billion by 2027 expanding at a reasonable CAGR of around 8.4% during the forecast period (2021-2027). Neuromodulation devices cure many neurological disorders like headache, depression, epilepsy etc. In fact, Headache disorders are the second and third most occurring disorders in the world. Most people have experienced atleast one headache episode in their lives. Pharmacoresistance and tolerance to common pharmacological therapies are making chronic headaches harder to treat. Also, interaction between different drugs can cause side-effects. Innovative non-invasive neuromodulatroy techniques are in the rise in today’s market. Many studies have been done in this field and they look promising. In fact, a very high-quality study done on episodic migraine using a percutaneious mastoid electrical stimulator showed an absolute difference of 2.87 days/month reduction rate. In another study of non–invasive vagus nerve stimulation (nVNS), those receiving nVNS in the randomized phase had 3.9 fewer attacks than the control group.

Download Free Sample of this Report- https://univdatos.com/get-a-free-sample-form-php/?product_id=4722

Another example of a neuromodulation device is the RNS System (from NeuroPace) which is a brain-responsive neuromodulation system approved by the US Food and Drug Administration for adults with medically intractable focal onset seizures. This therapy is generally used by patients with surgical resection or ablation due to unfavorable risk benefit profile or patient preference. As per WHO report in 2019, 50 million individuals worldwide, have epilepsy, which makes it one of the most common neurological diseases globally.
In an experiment, the reduction of seizure frequencies was noted using the NeuroPace RNS system. The study show that 67% reduction in seizure frequencies were seen in the first year, followed by a 75% reduction in frequency in the 2nd year and an 82% reduction in 3 and more years. This shows that neuromodulation is an effective technology to control the frequency of seizures. According to WHO 70% of the epilepsy patients can live a seizure free life if properly diagnosed and treated.

Download Free Sample of this Report- https://univdatos.com/get-a-free-sample-form-php/?product_id=4722

With the sudden rise of covid-19, all major healthcare companies are investing in R&D of respiratory devices. According to a report by Narayana Health 14% of all Covid infected patients will have pneumonia (an inflammation due to infection in one or both lung’s air sacs). Vagus nerve stimulation, which is a type of neurostimulation treatment involves delivering electrical pulses to the vagus nerve to cure the acute respiratory disease. Due to this there is a huge rise in investments in both private and public hospitals for neurology applications to help treat the illness. These devices are currently under the trial process to treat covid patients. If this trial turns out to be successful, then these devices will be found in most hospitals and clinics that are treating the deadly Sars-CoV-2 virus. One clinical trial is being performed by ElectroCore which is providing non-invasive vagus nerve stimulation to treat covid patients. Additionally, there are advancement in technology to enhance these devices with artificial intelligence, which is predicted to boost the market even further.

Based on technology the neuromodulation devices market is divided into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, transcranial magnetic stimulators, and others. There has been unprecedented growth in the neuromodulation field in the last decade, with novel chronic pain indications, hardware advancements and waveforms. In 2014, approximately 10,000 Neuromodulation devices were implanted in the United States. Spinal cord stimulation (SCS) is used in many refractory chronic pain conditions like complex regional pain syndrome, failed back surgery syndrome, angina pectoris, abdominal pain and ischemic limb pain.

Download Free Sample of this Report- https://univdatos.com/get-a-free-sample-form-php/?product_id=4722

Based on application, neuromodulation devices market is segmented into pain management, hearing loss, depression, parkinson’s disease, epilepsy, and others. Neuromodulation devices are medical tools used to increase or decrease the activity of the nervous system. This technology can be effective in reducing many nervous system related diseases, pain, hearing, epilepsy etc. According to WHO, there are currently 264 million people suffering from depression (2020) and 50 million people suffering from epilepsy (2019) worldwide. Additionally, the national institutes of health in 2020 published that, 1 in 5 people in the United States suffer from chronic pain.

Additionally, the report provides detailed initiatives that are being taken in the field of neuromodulation devices, globally. The report provide a detailed analysis of regions including North America (the U.S, Canada, and Rest of North America), Europe (Germany, France, Spain, Italy, UK, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of Asia-Pacific), and the Rest of the World. North America dominated the market in 2020, with --% share.

Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Nevro Corporation, St. Jude Medical, Inc., Neurosigma Inc., Neuronetics Inc., LivaNova PLC, Nuvectra, Cyberonics, are some of the prominent players operating in the global neuromodulation devices market. Several M&As along with partnerships have been undertaken by these players to develop a better and long-lasting treatments for neurological diseases.

Neuromodulation Devices Market Segmentation
Market Insight, by Technology
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Transcranial magnetic Stimulators
• Others

Market Insight, by Application
• Pain Management
• Hearing Loss
• Depression
• Parkinson's Disease
• Epilepsy
• Others
Market Insight, by Region
• North America Neuromodulation Devices Market
o United States
o Canada
o Rest of North America
• Europe Neuromodulation Devices Market
o France
o Germany
o Italy
o Spain
o United Kingdom
o Rest of Europe
• Asia-Pacific Neuromodulation Devices Market
o China
o Japan
o India
o Australia
o Rest of Asia-Pacific
• Rest of World Neuromodulation Devices Market

Download Free Sample of this Report- https://univdatos.com/get-a-free-sample-form-php/?product_id=4722

Top Company Profiles
• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic PLC
• Nevro Corporation
• St. Jude Medical, Inc.
• Neurosigma Inc.
• Neuronetics Inc.
• LivaNova PLC
• Nuvectra
• Cyberonics

Table Of Content

• •
MARKET INTRODUCTION
• RESEARCH METHODOLOGY OR ASSUMPTION
• INDUSTRY PERFORMANCE
• EXECUTIVE SUMMARY
• COVID-19 IMPACT
• MARKET INSIGHTS BY TECHNOLOGY
• MARKET INSIGHTS BY APPLICATION
• MARKET INSIGHTS BY REGION
• LEGAL AND REGULATORY FRAMEWORK
• DEMAND AND SUPPLY SIDE ANALYSIS
• VALUE CHAIN ANALYSIS
• NEUROMODULATION DEVICES MARKET TRENDS & INSIGHTS
• NEUROMODULATION DEVICES MARKET DYNAMICS
• COMPETITIVE SCENARIO
• COMPANY PROFILED
DISCLAIMER

Request for full report- https://univdatos.com/report/neuromodulation-devices-market/

CONTACT US
E-mail: sales@univdatos.com
Phone: +91 783860491
Address-: 4th & 5th Floor,
C80B, Sector 8, Noida,
Pin code- 201301, UP, India

About UnivDatos Market Insights

UnivDatos Market Insights (UMI) is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in delivering insights through Market Intelligence Reports, Customized Business Research, and Primary Research. Our research studies are spread across topics across the world, we cover markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, detailed analysis, and customized reports that help shape winning business strategies for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuromodulation Devices Market Top Key Players, Industry Analysis And Forecast By 2027 | Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC. here

News-ID: 2434775 • Views:

More Releases from UnivDatos Market Insights (UMI)

Airline Route Profitability Software Market - Industry Size, Share, Growth & Forecast 2028 | UnivDatos
Airline Route Profitability Software Market - Industry Size, Share, Growth & For …
The Airline Route Profitability Software Market is expected to grow at a steady rate of around 10% owing to the increased adoption of technologies such as artificial intelligence, mobile and conversational commerce coupled with business analytics and market intelligence. Thus, helping airlines to identify demand trends and increase profit margins by calculating and evaluating the cost of currently operated routes. Moreover, the rising need to find shorter as well as
Building Energy Management System Market - Industry Size, Share, Growth & Forecast 2028 | UnivDatos
Building Energy Management System Market - Industry Size, Share, Growth & Foreca …
Global Building Energy Management System market is expected to register a CAGR of around 11% over the period of 2022-2028. A building energy management system (BEMS) is a computer-based system that monitors and controls a building's electrical and mechanical equipment such as lighting, power systems, heating, and ventilation. Growth in technological advancement has made building energy management systems a vital component for managing energy demand, especially in large building sites.
Cloud Computing Market - Industry Analysis by Size, Share, Growth & Forecast (2022-2028) | UnivDatos
Cloud Computing Market - Industry Analysis by Size, Share, Growth & Forecast (20 …
Internet penetration rate and data generated yearly are some of the most prominent factors driving the growth of the cloud computing market because as the size of generated data increases the need for this data to be stored either in physical storage devices or in cloud storage also increases. Moreover, physical storage devices are easy to access but they are more expensive and less secure than cloud storage, there is
Perimeter Security Market Report 2022 - Global Business Trends, Emerging Growth, Key Factors, Business Development and Opportunities till 2028
Perimeter Security Market Report 2022 - Global Business Trends, Emerging Growth, …
Perimeter security refers to an integrated system that enables the physical security of a facility. It helps in protecting against unauthorized physical intrusion. Outdoor perimeter security includes technologies such as video surveillance systems, access control systems, communication and notification systems, and intruder detection systems. Recent technological advances have introduced infrared, microwave, radar, and seismic sensors. This has contributed to the robustness of these systems. Download a Sample Copy of this Report

All 5 Releases


More Releases for Neuromodulation

Internal Neuromodulation Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Internal Neuromodulation market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This report is
Neuromodulation Devices Market 2022 | Detailed Report
The Neuromodulation Devices research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,
Neuromodulation Market Overview and Industry Outlook 2020
Global Neuromodulation Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Neuromodulation Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected
Neuromodulation Market Thriving Worldwide $11,717 Million By 2022
The global neuromodulation market size is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. The global neuromodulation devices market is estimated to reach $11,717 million by 2022. For More Info, Get PDF Sample : http://bit.ly/2BciOaa Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease affect the central and peripheral nervous system. Bacterial, viral, and fungal infections
Global Neuromodulation Devices Market 2027: Comprehensive Report Study
Market Research Future published a research report on “Global Neuromodulation Devices Market Research Report- Forecast To 2027” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027. Global neuromodulation devices market Information, by types by Techniques Applications - Forecast to 2027 Globally the market for neuromodulation devices is increasing rapidly. The major factor that derives the growth of neuromodulation devices is the increasing development neuromodulation devices. Furthermore increasing demand
Sacral Neuromodulation Systems Market Outlook to 2025
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities. According to a study on neuromodulation devices and therapies, neuromodulation is a safe, effective, and long term treatment for chronic pain and movement disorders. Neuromodulation technology is gaining momentum